CULLINAN THERAPEUTICS, INC. Shares Issued
CULLINAN THERAPEUTICS, INC. (CGEM) had Shares Issued of 64.35 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares, Issued 64.35M shares.
- 2026-03-31: Common Stock, Shares, Issued 61.45M shares.
- 2025-12-31: Common Stock, Shares, Issued 60.24M shares.
- 2025-09-30: Common Stock, Shares, Issued 59.08M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 64.35M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 61.45M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 60.24M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 59.08M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 59.07M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 58.70M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 58.51M shares 10-K · filed 2026-03-10 | |
| 2024-09-30 | 58.14M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 57.87M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 43.07M shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 42.90M shares 10-K · filed 2025-02-27 | |
| 2023-09-30 | 42.76M shares 10-Q · filed 2023-11-08 | |
| 2023-06-30 | 42.74M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 39.34M shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 45.80M shares 10-K · filed 2024-03-14 | |
| 2022-09-30 | 45.74M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 45.40M shares 10-Q · filed 2022-08-10 | |
| 2022-03-31 | 44.66M shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 44.29M shares 10-K · filed 2023-03-09 | |
| 2021-09-30 | 43.66M shares 10-Q · filed 2021-11-09 | |
| 2021-06-30 | 43.53M shares 10-Q · filed 2021-08-10 | |
| 2021-03-31 | 43.52M shares 10-Q · filed 2021-05-14 | |
| 2020-12-31 | 29.83M shares 10-K · filed 2022-03-17 | 29.38M shares 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |